Barclays’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Buy |
132,341
+64,575
| +95% | +$1.49M | ﹤0.01% | 1952 |
|
|
2025
Q1 | $1.83M | Sell |
67,766
-196,204
| -74% | -$5.3M | ﹤0.01% | 2087 |
|
|
2024
Q4 | $14.1M | Buy |
263,970
+89,909
| +52% | +$4.81M | ﹤0.01% | 909 |
|
|
2024
Q3 | $7.91M | Buy |
174,061
+144,883
| +497% | +$6.58M | ﹤0.01% | 1175 |
|
|
2024
Q2 | $1.22M | Buy |
29,178
+13,678
| +88% | +$573K | ﹤0.01% | 2010 |
|
|
2024
Q1 | $584K | Sell |
15,500
-32,222
| -68% | -$1.21M | ﹤0.01% | 2744 |
|
|
2023
Q4 | $511K | Buy |
47,722
+29,800
| +166% | +$319K | ﹤0.01% | 2983 |
|
|
2023
Q3 | $181K | Buy |
17,922
+12,443
| +227% | +$126K | ﹤0.01% | 3078 |
|
|
2023
Q2 | $65K | Sell |
5,479
-3,425
| -38% | -$40.6K | ﹤0.01% | 3561 |
|
|
2023
Q1 | $108K | Buy |
8,904
+4,296
| +93% | +$52.1K | ﹤0.01% | 3484 |
|
|
2022
Q4 | $61K | Buy |
4,608
+3,880
| +533% | +$51.4K | ﹤0.01% | 3700 |
|
|
2022
Q3 | $10K | Sell |
728
-132
| -15% | -$1.81K | ﹤0.01% | 4174 |
|
|
2022
Q2 | $11K | Sell |
860
-2,088
| -71% | -$26.7K | ﹤0.01% | 4290 |
|
|
2022
Q1 | $42K | Buy |
+2,948
| New | +$42K | ﹤0.01% | 4066 |
|